Five-Year Safety and Efficacy of Belatacept in Renal Transplantation

Belatacept is a first-in-class co-stimulation blocker in development for primary maintenance immunosuppression. A Phase II study comparing belatacept with cyclosporine (CsA) for prevention of acute rejection and protection of renal function in kidney transplant recipients demonstrated similar effica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vincenti, Flavio, Blancho, Gilles, Durrbach, Antoine, Friend, Peter, Grinyo, Josep, Halloran, Philip F., Klempnauer, Jurgen, Lang, Philippe, Larsen, Christian P., Mühlbacher, Ferdinand, Nashan, Björn, Soulillou, Jean-Paul, Vanrenterghem, Yves, Wekerle, Thomas, Agarwal, Mamta, Gujrathi, Sheila, Shen, Jinshan, Shi, Rebecca, Townsend, Robert, Charpentier, Bernard
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Nephrology 2010
Schlagworte:
Clinical Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3013525/
https://ncbi.nlm.nih.gov/pubmed/20634298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009111109
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge